Mutated Gene Found in Families with Multiple Tumors
By LabMedica International staff writers Posted on 05 Oct 2015 |
Image: The replacement of the amino acid arginine by a cysteine at position 117 in POT1p.R117C produces conformational changes in the protein that are incompatible with an efficient connection to the telomere, inducing an aberrant telomere elongation and fragile telomeres in the mutated cells (Photo courtesy of CNIO).
Cardiac angiosarcoma (CAS) is a rare but malignant disease and in the case of hereditary CAS, the median survival expectancy is only four months because the disease is diagnosed at an advanced stage.
No genes responsible for CAS cases have been identified so far, thus hampering early diagnosis and effective treatment, which involves surgical excision combined with chemotherapy, and heart transplantation only for patients with no evidence for metastasis.
Scientists at the Spanish National Cancer Research Center (CNIO; Madrid, Spain), and their colleagues selected index cases from Li–Fraumeni-like (LFL) families negative for mutations and large deletions of the tumor protein 53 (TP53) gene. Three of the families had members affected with CAS plus other tumors. The rest of the families fulfilled the LFL criteria but they did not have any member with a CAS tumor. A group of 1,520 samples from a Spanish control population was used for genotyping the protection of telomeres 1(POT1) variant by denaturing high performance liquid chromatography.
The team used a multiplicity of techniques to find a novel damaging missense variant (p.R117C) in the POT1 gene in TP53-negative LFL families with CAS and other tumors. The discovery of the new mutation proved to be even more significant from a clinical perspective, given that it identified carriers at risk of developing cardiac angiosarcoma and possibly other tumors. The study confirms that POT1 plays a novel role in the development of different forms of hereditary cancer. The key is in the telomeres. When anomalies occur in the telomeres, the chromosomes become unstable, this, in turn, leads to extended genomic instability. POT1 is a central component of the telomeres that functions incorrectly when mutated.
Javier Benítez, PhD, a senior author of the study, said, “In the past, we simply didn't have anything that could help in identifying these people at risk, because there were no markers for familial CAS or for families with a syndrome similar to Li-Fraumeni without P53 mutations. This study uncovers one of the genes that explains the high incidence of cancer in some of them. The translation of these results into the clinic is immediate. In fact, we are already helping families that carry this mutation.” The study was published on September 25, 2015, in the journal Nature Communication.
Related Links:
Spanish National Cancer Research Center
No genes responsible for CAS cases have been identified so far, thus hampering early diagnosis and effective treatment, which involves surgical excision combined with chemotherapy, and heart transplantation only for patients with no evidence for metastasis.
Scientists at the Spanish National Cancer Research Center (CNIO; Madrid, Spain), and their colleagues selected index cases from Li–Fraumeni-like (LFL) families negative for mutations and large deletions of the tumor protein 53 (TP53) gene. Three of the families had members affected with CAS plus other tumors. The rest of the families fulfilled the LFL criteria but they did not have any member with a CAS tumor. A group of 1,520 samples from a Spanish control population was used for genotyping the protection of telomeres 1(POT1) variant by denaturing high performance liquid chromatography.
The team used a multiplicity of techniques to find a novel damaging missense variant (p.R117C) in the POT1 gene in TP53-negative LFL families with CAS and other tumors. The discovery of the new mutation proved to be even more significant from a clinical perspective, given that it identified carriers at risk of developing cardiac angiosarcoma and possibly other tumors. The study confirms that POT1 plays a novel role in the development of different forms of hereditary cancer. The key is in the telomeres. When anomalies occur in the telomeres, the chromosomes become unstable, this, in turn, leads to extended genomic instability. POT1 is a central component of the telomeres that functions incorrectly when mutated.
Javier Benítez, PhD, a senior author of the study, said, “In the past, we simply didn't have anything that could help in identifying these people at risk, because there were no markers for familial CAS or for families with a syndrome similar to Li-Fraumeni without P53 mutations. This study uncovers one of the genes that explains the high incidence of cancer in some of them. The translation of these results into the clinic is immediate. In fact, we are already helping families that carry this mutation.” The study was published on September 25, 2015, in the journal Nature Communication.
Related Links:
Spanish National Cancer Research Center
Latest Pathology News
- AI Integrated With Optical Imaging Technology Enables Rapid Intraoperative Diagnosis
- HPV Self-Collection Solution Improves Access to Cervical Cancer Testing
- Hyperspectral Dark-Field Microscopy Enables Rapid and Accurate Identification of Cancerous Tissues
- AI Advancements Enable Leap into 3D Pathology
- New Blood Test Device Modeled on Leeches to Help Diagnose Malaria
- Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing
- Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization
- First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests
- AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis
- New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance
- New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis
- Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse
- Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection
- Image-Based AI Shows Promise for Parasite Detection in Digitized Stool Samples
- Deep Learning Powered AI Algorithms Improve Skin Cancer Diagnostic Accuracy
- Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities